EVALUATION OF AMINO ACID PROFILE IN SERUM OF PATIENTS WITH COVID-19 FOR PROVIDING A NEW TREATMENT STRATEGY
dc.authorid | Bozok, Taylan/0000-0002-7094-4838 | |
dc.authorid | Ibrahim, Bashar/0000-0001-7773-0122 | |
dc.contributor.author | Ozturkl, Ali | |
dc.contributor.author | Bayraktar, Nihayet | |
dc.contributor.author | Bayraktar, Mustafa | |
dc.contributor.author | Ibrahim, Bashar | |
dc.contributor.author | Bozok, Taylan | |
dc.contributor.author | Ceylan, Mehmet Resat | |
dc.date.accessioned | 2024-11-07T13:35:00Z | |
dc.date.available | 2024-11-07T13:35:00Z | |
dc.date.issued | 2022 | |
dc.department | Niğde Ömer Halisdemir Üniversitesi | |
dc.description.abstract | BackgroundAmino acids have an important role in metabolism and may affect COVID-19-related outcomes. In our study, the amino acid serum level of hospitalized COVID19 patients was evaluated to determine a new treatment strategy.MethodsThe amino acid profile covering 43 amino acids in 68 subjects, comprising 30 (14 men and 16 women) controls and 38 (16 men and 22 women) COVID-19 patients, were examined. The amino acid profiles of the participants were screened by LC-MS/MS.ResultsCompared with the control group, serum levels of 27 amino acids increased in the patient group. Alpha-aminopimelic acid, sarcosine, and hydroxyproline amino acids were considerably higher in the control group than in the patient group (p<0.0001). There was no notable difference among control group and the case group for 13 amino acids (p >= 0.05). A significant positive correlation was seen among the control and the patient groups in the mean amino acid values (r=0.937; p<0.0001).ConclusionsThese results postulated a clear picture on the serum levels of amino acid in the COVID-19 patients. Serum amino acids measured in hospitalized COVID-19 patients can explain the patient's metabolic status during the disease. | |
dc.identifier.doi | 10.5937/jomb0-37514 | |
dc.identifier.endpage | 533 | |
dc.identifier.issn | 1452-8258 | |
dc.identifier.issn | 1452-8266 | |
dc.identifier.issue | 4 | |
dc.identifier.pmid | 36381071 | |
dc.identifier.scopus | 2-s2.0-85141321901 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 526 | |
dc.identifier.uri | https://doi.org/10.5937/jomb0-37514 | |
dc.identifier.uri | https://hdl.handle.net/11480/16270 | |
dc.identifier.volume | 41 | |
dc.identifier.wos | WOS:000954576000013 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Soc Medical Biochemists Serbia | |
dc.relation.ispartof | Journal of Medical Biochemistry | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241106 | |
dc.subject | amino acid | |
dc.subject | Covid-19 | |
dc.subject | Sars-CoV-2 | |
dc.subject | treatment strategy | |
dc.title | EVALUATION OF AMINO ACID PROFILE IN SERUM OF PATIENTS WITH COVID-19 FOR PROVIDING A NEW TREATMENT STRATEGY | |
dc.title.alternative | PROCENA AMINOKISELINSKOG PROFILA U SERUMU PACIJENATA SA COVID-19 ZA OBEZBE\IVANJE NOVE STRATEGIJE LE^ENJA | |
dc.type | Article |